Enveric Biosciences Inc (ENVB) Stock: What Does the Chart Say Monday?

Enveric Biosciences Inc (ENVB) stock is down 18.12% over the past week and gets a Bearish rating from InvestorsObserver Sentiment Indicator.

Enveric Biosciences Inc has a Bearish sentiment reading. Find out what this means for you and get the rest of the rankings on ENVB!

See Full ENVB Report

What is Stock Sentiment?

Sentiment uses short term technical analysis to gauge whether a stock is desired by investors. As a technical indicator, it focuses on recent trends as opposed to the long term health of the underlying company. Updates for the company such as a earnings release can move the stock away from current trends. Sentiment is how investors, or the market, feels about a stock. There are lots of ways to measure sentiment. At the core, sentiment is pretty easy to understand. If a stock is going up, investors must be bullish, while if it is going down, sentiment is bearish. InvestorsObserver’s Sentiment Indicator looks at price trends over the past week and also considers changes in volume. Increasing volume can mean a trend is getting stronger, while decreasing volume can mean a trend is nearing a conclusion. For stocks that have options, our system also considers the balance between calls, which are often bets that the price will go up, and puts, which are frequently bets that the price will fall.

What's Happening With ENVB Stock Today?

Enveric Biosciences Inc (ENVB) stock is lower by -2.17% while the S&P 500 has gained 0.86% as of 10:43 AM on Monday, Dec 6. ENVB is down -$0.02 from the previous closing price of $1.15 on volume of 403,141 shares. Over the past year the S&P 500 has gained 23.98% while ENVB is down -82.34%. ENVB lost -$1.13 per share in the over the last 12 months. To screen for more stocks like Enveric Biosciences Inc click here.

More About Enveric Biosciences Inc

Enveric Biosciences Inc is a patient-centric biotechnology company focused on developing new-generation, naturally occurring chemical compounds, such as cannabinoids to improve the lives of those who are adversely affected by the side effects of cancer treatments. Its product in the pipeline includes Glioblastoma Multiforme (GBM); Radiation Dermatitis and Chemotherapy-Induced Peripheral Neuropathy (CIPN). Click Here to get the full Stock Report for Enveric Biosciences Inc stock.